IMMUNOMEDICS INC Business Operations Contracts & Agreements
13 Contracts & Agreements
- Collaboration Agreements (3 contracts)
- Indemnification Agreements (2)
- Sales Agreements (1)
- Services Agreements (2)
- Settlement Agreements (1)
- Termination Agreements (4)
- Sales Agreement, dated as of March 29, 2019, by and between Immunomedics, Inc. and Cowen and Company, LLC (Filed With SEC on March 29, 2019)
- Master Services Agreement, dated as of September 11, 2018, between the Company and Samsung BioLogics Co., Ltd (Filed With SEC on November 7, 2018)
- Form of Indemnification Agreement (Filed With SEC on December 6, 2017)
- Master Services Agreement, dated as of July 3, 2017, between the Company and Covance, Inc (Filed With SEC on November 9, 2017)
- Stipulation and Agreement of Settlement, Compromise, and Release, dated November 2, 2017, by and among Immunomedics, Inc., venBio Select Advisor LLC, Dr. David M. Goldenberg,... (Filed With SEC on November 8, 2017)
- TERMINATION AGREEMENT (Filed With SEC on August 16, 2017)
- INDEMNIFICATION AGREEMENT (Filed With SEC on February 16, 2017)
- AMENDMENT AGREEMENT Re: Epratuzumab Development, Collaboration and License Agreement (Filed With SEC on February 8, 2012)
- LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on August 29, 2008)
- TERMINATION AGREEMENT (Filed With SEC on December 26, 2007)
- TERMINATION AGREEMENT (Filed With SEC on September 13, 2007)
- TERMINATION AGREEMENT (Filed With SEC on September 13, 2007)
- DEVELOPMENT, COLLABORATION AND LICENSE AGREEMENT between (Filed With SEC on August 29, 2006)